Ribavirin

Form: Tablets, Capsules and Oral Solution

Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

Category: Hepatitis

Ribavirin is a broad-spectrum antiviral used in combination with other agents, such as Interferon Alfa or Sofosbuvir, for the treatment of chronic Hepatitis C virus (HCV) infection. Available in oral capsule and tablet forms, Ribavirin enhances antiviral efficacy by inhibiting viral RNA replication. It is commonly prescribed in combination regimens to improve sustained virologic response (SVR) in HCV patients. Ribavirin is FDA and EMA approved and marketed under various brands like Rebetol® and Copegus®. It remains a key product in pharma B2B hepatitis portfolios for both US and EU healthcare markets, particularly in resource-limited or genotype-specific treatment settings.